Polymorphism of amyloid-β fibrils and its effects on human erythrocyte catalase binding

Micron

Volumn 40, Issue 8, 2009, Pages 800-810

  Milton, Nathaniel G N ^a   Harris, J Robin ^b,c  

^a UNIVERSITY OF ROEHAMPTON   (United Kingdom)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's; Amyloid ; Congo red; Fibril; Human erythrocyte catalase; Polymorphism; TEM

Indexed keywords

ALZHEIMER'S; CONGO RED; FIBRIL; HUMAN ERYTHROCYTE CATALASE; TEM;

AMINO ACIDS; AZO DYES; GLYCOPROTEINS; ORGANIC ACIDS; PEPTIDES; POLYMORPHISM;

AMINES;

AMYLOID; CATALASE; CONGO RED;

ARTICLE; ENZYMOLOGY; ERYTHROCYTE; HUMAN; METABOLISM; METHODOLOGY; PROTEIN BINDING; SPECTROPHOTOMETRY; STAINING; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

AMYLOID; CATALASE; CONGO RED; ERYTHROCYTES; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; PROTEIN BINDING; SPECTROPHOTOMETRY; STAINING AND LABELING;

EID: 69249205408     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2009.07.006     Document Type: Article

References (69)

1. Arimon M., Grimminger V., Sanz F., and Lashuel H.A. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Aβ fibrils and protofibrils. J. Mol. Biol. 384 (2008) 1157-1173
2. Bitan G., Kirkitadze M., Lomakin A., Vollers S., Benedek G., and Teplow D. Amyloid β-protein (Aβ) assembly: Aβ 40 and Aβ 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 330-335
3. Bitan G., Vollers S., and Teplow D. Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. J. Biol. Chem. 278 (2003) 34882-34889
4. Behl C., Davies J.B., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77 (1994) 817-827
5. Cheng L., Yin W.J., Zhang J.F., and Qi J.S. Amyloid β-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo. Synapse 63 (2009) 206-214
6. Fändrich M. On the structural definition of amyloid fibrils and other polypeptide aggregates. Cell. Mol. Life Sci. 64 (2007) 2066-2078
7. Fezoui Y., Hartley D.M., Harper J.D., Khurana R., Walsh D.M., Condron M.M., Selkoe D.J., Lansbury Jr. P.T., Fink A.L., and Teplow D.B. An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments. Amyloid 7 (2000) 166-178
8. Findeis M.A. The role of amyloid β peptide 42 in Alzheimer's disease. Pharmacol. Ther. 116 (2007) 266-286
9. Fita I., and Rossmann M.G. The active center of catalase. J. Mol. Biol. 185 (1985) 21-37
10. Fowler D.M., Koulov A.V., Balch W.E., and Kelly J.W. Functional amyloid-from bacteria to humans. Trends Biochem. Sci. 32 (2007) 217-224
11. Frieden C. Protein aggregation processes: in search of the mechanism. Protein Sci. 16 (2007) 2334-2344
12. Gellermann G.P., Byrnes H., Striebinger A., Ullrich K., Mueller R., Hillen H., and Barghorn S. Aβ-globulomers are formed independently of the fibril pathway. Neurobiol. Dis. 30 (2008) 212-220
13. Goldsbury C., Frey P., Olivieri V., Aebi U., and Müller S.A. Multiple assembly pathways underlie amyloid-beta fibril polymorphisms. J. Mol. Biol. 352 (2005) 282-298
14. Harper J.D., and Lansbury Jr. P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
15. Harris J.R. Cholesterol binding to amyloid-β fibrils: a TEM study. Micron 39 (2008) 1192-1196
16. Harris J.R. Negative staining across holes: application to fibril and tubular structures. Micron 39 (2008) 168-176
17. Harris J.R. Amyloid-β fibril formation in vitro. In: Harris J.R., Graham J., and Rickwood D. (Eds). Cell Biology Protocols (2007), John Wiley and Sons Ltd., Chichester, UK 345-347
18. Harris J.R. The contribution of microscopy to the study of amyloid plaques and to amyloid-β fibrillogenesis. In: Harris R., and Fahrenholz F. (Eds). Alzheimer's disease: cellular and molecular aspects of amyloid β. Subcellular biochemistry vol. 38 (2005), Springer Science 1-44
19. 1-42 peptide: cholesterol potentiation and aspirin inhibition. Micron 33 (2002) 609-626
20. Harris J.R. Negative Staining and Cryoelectron Microscopy: the thin film techniques. Royal Microscopical Society Handbook No. 35 (1997), Bios Scientific Publishers, Oxford
21. Harris J.R., and Holzenburg A. Human erythrocyte catalase: 2D crystal nucleation andproduction of multiple crystal forms. J. Struct. Biol. 115 (1995) 102-112
22. Harris J.R., Engelhardt H., Volker S., and Holzenburg A. Electron microscopy of human erythrocyte catalase: new two-dimensional crystal forms. J. Struct. Biol. 111 (1993) 22-33
23. Harris J.R., and Holzenburg A. Transmisison electron microscopic studies on the quaternary structure of human erythrocyte catalase. Micron Microsc. Acta 20 (1989) 223-238
24. Inouye H., and Kirschner D.A. Alzheimer's β-amyloid: insights into fibril formation and structure from Congo red binding. In: Harris R., and Fahrenholz F. (Eds). Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid β. Subcellular Biochemistry vol. 38 (2005), Springer Science 203-224
25. Jarrett J.T., and Lansbury Jr. P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 73 (1993) 1055-1058
26. Kandiah N., and Feldman H.H. Therapeutic potential of statins in Alzheimer's disease. J. Neurol. Sci. 283 (2009) 230-234
27. Karsai A., Mártonfalvi Z., Nagy A., Grama L., Penke B., and Kellermayer M.S. Mechanical manipulation of Alzheimer's amyloid β 1-42 fibrils. J. Struct. Biol. 155 (2006) 316-326
28. Kim W., and Hecht M.H. Sequence determinants of enhanced amyloidogenicity of Alzheimer Aβ 42 peptide relative to Aβ 40. J. Biol. Chem. 280 (2005) 35069-35076
29. Kirkman H.N., and Gaetani G.F. Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 4343-4347
30. Klunk W.E., Pettegrew J.W., and Abraham D.J. Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J. Histochem. Cytochem. 37 (1989) 1273-1281
31. Klunk W.E., Jacob R.F., and Mason R.P. Quantifying amyloid by Congo red spectral shift assay. Methods Enzymol. 309 (1999) 285-305
32. LeVine H., and Walker L.C. Molecular polymorphism of Aβ in Alzheimer's disease. Neurobiol. Aging (2008) 10.1016/j.neurobiolaging.2008.05.026
33. Li L., Darden T.A., Bartolotti L., Kominos D., and Pedersen L.G. An atomic model for the pleated β-sheet structure of Aβ amyloid protofilaments. Biophys. J. 76 (1999) 2871-2878
34. Liao M.Q., Tzeng Y.J., Chang L.Y., Huang H.B., Lin T.H., Chyan C.L., and Chen Y.C. The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides. FEBS Lett. 581 (2007) 1161-1165
35. Liu R., McAllister C., Lyubchenko Y., and Sierks M.R. Residues 17-20 and 30-35 of β-amyloid play critical roles in aggregation. J. Neurosci. Res. 75 (2004) 162-171
36. Lovell M.A., Ehmann W.D., Butler S.M., and Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimers disease. Neurology 45 (1995) 1594-1601
37. Ma X., Liu L., Mao X., Niu L., Deng K., Wu W., Li Y., Yang Y., and Wang C. Amyloid β (1-42) folding multiplicity and single-molecule binding behavior studied with STM. J. Mol. Biol. 388 (2009) 894-901
38. Malinchik S.B., Inouye H., Szumowski K.E., and Kirschner D.A. Structural analysis of Alzheimer"s β (1-40) amyloid: protofilament assembly of tubular fibrils. Biophys. J. 74 (1998) 537-545
39. Marcelino A.M., and Gierasch L.M. Roles of β-turns in protein folding: from peptide models to protein engineering. Biopolymers 89 (2008) 380-391
40. Meinhardt J., Sachse C., Hortschansky P., Grigorieff N., and Fändrich M. Aβ(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J. Mol. Biol. 386 (2009) 869-877
41. Milton N.G.N. Amyloid-β binds Catalase with high affinity and inhibits hydrogen peroxide breakdown. Biochem. J. 344 (1999) 293-296
42. Milton N.G.N., Mayor N.P., and Rawlinson J. Identification of amyloid-β binding sites using an antisense peptide approach. Neuroreport 12 (2001) 2561-2566
43. Milton N.G.N. Inhibition of catalase activity with 3-amino-triazole enhances the cytotoxicity of the Alzheimer's amyloid-β peptide. Neurotoxicology 22 (2001) 767-774
44. Mothes E., Shoeman R.L., Schröder R.R., and Traub P. Polymerizing properties of pepstatin A. J. Struct. Biol. 105 (1990) 80-91
45. Nordling E., Kallberg Y., Johansson J., and Persson B. Molecular dynamics studies of alpha-helix stability in fibril-forming peptides. J. Comput. Aided Mol. Des. 22 (2008) 53-58
46. Olofsson A., Lindhagen-Persson M., Sauer-Eriksson A.E., and Ohman A. Amide solvent protection analysis demonstrates that amyloid-β (1-40) and amyloid-β (1-42) form different fibrillar structures under identical conditions. Biochem. J. 404 (2007) 63-70
47. Pappolla M.A., Omar R.A., Kim K.S., and Robakis N.K. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am. J. Pathol. 140 (1992) 621-628
48. Paravastu A.K., Leapman R.D., Yau W.M., and Tycko R. Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 18349-18354
49. Pellarin R., and Caflisch A. Interpreting the aggregation kinetics of amyloid peptides. J. Mol. Biol. 360 (2006) 882-892
50. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., and Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307 (2005) 262-265
51. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., and Cotman C.W. Structure-activity analyses of β-amyloid peptides: contributions of the β 25-35 region to aggregation and neurotoxicity. J. Neurochem. 64 (1995) 253-265
52. Putnam C.D., Arvai A.S., Bourne Y., and Tainer J.A. Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism. J. Mol. Biol. 296 (2000) 295-309
53. Safo M.K., Musayev F.N., Wu S.H., Abraham D.J., and Ko T.P. Structure of tetragonal crystals of human erythrocyte catalase. Acta Crystallogr. D: Biol. Crystallogr. 57 (2001) 1-7
54. Scanlon S., and Aggeli A. Self-assembling peptide nanotubes. Nanotoday 3 (2008) 22-30
55. Selkoe D.J. Biochemistry and molecular biology of amyloid β-protein and the mechanism of Alzheimer's disease. Handb. Clin. Neurol. 89 (2008) 245-260
56. Sipe J.D., and Cohen A.S. Review: history of the amyloid fibril. J. Struct. Biol. 130 (2000) 88-98
57. Soto C., Castaño E.M., Frangione B., and Inestrosa N.C. The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. Biol. Chem. 270 (1995) 3063-3067
58. Soto C., Sigurdsson E.M., Morelli L., Kumar R.A., Castaño E.M., and Frangione B. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat. Med. 4 (1998) 822-826
59. Stromer T., and Serpell L.C. Structure and morphology of the Alzheimer' amyloid fibril. Microsc. Res. Technol. 67 (2005) 210-217
60. Tjernberg L.O., Callaway D.J., Tjernberg A., Hahne S., Lilliehöök C., Terenius L., Thyberg J., and Nordstedt C. A molecular model of Alzheimer amyloid β-peptide fibril formation. J. Biol. Chem. 274 (1999) 12619-12625
61. Urbanc B., Cruz L., Ding F., Sammond D., Khare S., Buldyrev S.V., Stanley H.E., and Dokholyan N.V. Molecular dynamics simulation of amyloid beta dimer formation. Biophys. J. 87 (2004) 2310-2321
62. Wetzel R., Shivaprasad S., and Williams A.D. Plasticity of amyloid fibrils. Biochemistry 46 (2007) 1-10
63. Yagi H., Ban T., Morigaki K., Naiki H., and Goto Y. Visualization and classification of amyloid β supramolecular assemblies. Biochemistry 46 (2007) 15009-15017
64. Yoshiike Y., Akagi T., and Takashima A. Surface structure of amyloid-β fibrils contributes to cytotoxicity. Biochemistry 46 (2007) 9805-9812
65. Yu L., Edalji R., Harlan J.E., Holzman T.F., Lopez A.P., Labkovsky B., Hillen H., Barghorn S., Ebert U., Richardson P.L., Miesbauer L., Solomon L., Bartley D., Walter K., Johnson R.W., Hajduk P.J., and Olejniczak E.T. Structural characterization of a soluble amyloid β-peptide oligomer. Biochemistry 48 (2009) 1870-1877
66. Zagorski M.G., Yang J., Shao H., Ma K., Zeng H., and Hong A. Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity. Methods Enzymol. 309 (1999) 189-204
67. Zhang A., Qi W., Good T.A., and Fernandez E.J. Structural differences between Abeta(1-40) intermediate oligomers and fibrils elucidated by proteolytic fragmentation and hydrogen/deuterium exchange. Biophys. J. 96 (2009) 1091-1104
68. Zhang R., Hu X., Khant H., Ludtke S.J., Chiu W., Schmid M.F., Frieden C., and Lee J.M. Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM. Proc. Natl. Acad. Sci. U.S.A. 106 (2009) 4653-4658
69. 2 generation. J. Neurochem. 67 (1996) 1595-1606